Inozyme Pharma, Inc.
Total Trades
16
Buys
12
Sells
2
Largest Trade
N/A
Insiders
7
Institutional Funds
18
Inst. Value
$1M+
Activist Filings
43
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Treco Douglas A | CEO & Chairman | SELL | $1K–$15K | 9K | $0.89 | Apr 3, 2025 |
| Treco Douglas A | CEO & Chairman | EXERCISE | N/A | 25K | — | Apr 3, 2025 |
| Treco Douglas A | CEO | SELL | $50K–$100K | 8K | $6.94 | Apr 3, 2024 |
| Treco Douglas A | CEO | EXERCISE | N/A | 25K | — | Apr 3, 2024 |
| Pivotal bioVenture Partners Fund I, L.P. | Director | BUY | $1M+ | 833K | $4.80 | Aug 4, 2023 |
| Hopfner Robert Lorne | Director | BUY | $1M+ | 833K | $4.80 | Aug 4, 2023 |
| Hopfner Robert Lorne | Director | BUY | $1M+ | 448K | $6.36 | May 15, 2023 |
| Hopfner Robert Lorne | Director | BUY | $1M+ | 345K | $4.54 | Mar 30, 2023 |
| Hopfner Robert Lorne | Director | BUY | $500K+ | 208K | $4.05 | Mar 29, 2023 |
| Bjarke Henric Bjorn | SVP, COO | BUY | $15K–$50K | 22K | $1.39 | Dec 19, 2022 |
| Longitude Capital Partners III, LLC | 10% Owner | BUY | $1M+ | 1.4M | $3.69 | Apr 21, 2022 |
| Pivotal bioVenture Partners Fund I, L.P. | Director | BUY | $1M+ | 1.1M | $3.69 | Apr 20, 2022 |
| Bjarke Henric Bjorn | SVP, COO | BUY | $50K–$100K | 27K | $3.69 | Apr 20, 2022 |
| Bolte Axel | CEO | BUY | $100K–$500K | 68K | $3.69 | Apr 20, 2022 |
| Hopfner Robert Lorne | Director | BUY | $1M+ | 1.1M | $3.69 | Apr 20, 2022 |
| Subramanian Sanjay | SVP, CFO | BUY | $50K–$100K | 27K | $3.69 | Apr 20, 2022 |
Institutional Ownership
13F filings as of Jun 30, 2025 · 18 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| GLAZER CAPITAL, LLC | 4.3M | $1M+ | SH |
| MILLENNIUM MANAGEMENT LLC | 482K | $1M+ | SH |
| Sanofi | 443K | $1M+ | SH |
| CREDIT INDUSTRIEL ET COMMERCIAL | 149K | $500K+ | SH |
| Squarepoint Ops LLC | 48K | $100K–$500K | SH |
| Vanguard Personalized Indexing Management, LLC | 22K | $50K–$100K | SH |
| JANE STREET GROUP, LLC | 21K | $50K–$100K | SH |
| Parallel Advisors, LLC | 16K | $50K–$100K | SH |
| Hudson Bay Capital Management LP | 15K | $50K–$100K | SH |
| Tower Research Capital LLC (TRC) | 13K | $50K–$100K | SH |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 4K | $1K–$15K | SH |
| Mirae Asset Global Investments Co., Ltd. | 2K | $1K–$15K | SH |
| GF FUND MANAGEMENT CO. LTD. | 2K | $1K–$15K | SH |
| ROYAL BANK OF CANADA | 1K | $1K–$15K | SH |
| NISA INVESTMENT ADVISORS, LLC | 919 | $1K–$15K | SH |
| RAYMOND JAMES FINANCIAL INC | 400 | $1K–$15K | SH |
| IFP Advisors, Inc | 0 | $1K–$15K | SH |
| MORGAN STANLEY | 76 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Pivotal bioVenture Partners Fund I, L.P.
SC 13D/A · Aug 27, 2025
0.0%
0 shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
Rock Springs Capital Management LP
SC 13G/A · Aug 13, 2025
0.0%
0 shares
Adage Capital Management, L.P.
SC 13G/A · Aug 12, 2025
0.0%
0 shares
SC 13G/A · Jul 17, 2025
4.1%
2.7M shares
SC 13G · Jun 4, 2025
6.6%
4.3M shares
SC 13G/A · May 30, 2025
2.9%
1.9M shares
SC 13G · May 23, 2025
9.8%
6.3M shares
Eventide Asset Management, LLC
SC 13G/A · Apr 23, 2025
3.5%
2.2M shares
SC 13G/A · Feb 14, 2025
0.0%
0 shares
Eventide Asset Management, LLC
SC 13G/A · Feb 14, 2025
3.5%
2.2M shares
Affinity Healthcare Fund, LP (EIN 82-1629802)
SC 13G · Dec 9, 2024
6.2%
4.0M shares
Eventide Asset Management, LLC
SC 13G/A · Nov 14, 2024
6.4%
4.1M shares
SC 13G · Nov 8, 2024
5.6%
3.5M shares
SC 13G · Oct 24, 2024
5.6%
3.5M shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Feb 21, 2024
6.9%
4.3M shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G/A · Feb 15, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Rock Springs Capital Management LP
SC 13G/A · Feb 14, 2024
6.0%
3.7M shares
SC 13G · Feb 14, 2024
5.5%
3.4M shares
Eventide Asset Management, LLC
SC 13G · Feb 14, 2024
5.2%
3.2M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Pivotal bioVenture Partners Fund I, L.P. 2.
SC 13D/A · Feb 13, 2024
292.3M shares
SC 13G/A · Jan 16, 2024
1.5%
911K shares
Longitude Capital Partners III, LLC
SC 13D/A · Aug 11, 2023
7.1%
4.2M shares
Pivotal bioVenture Partners Fund I, L.P.
SC 13D/A · Aug 8, 2023
6.2%
2.9M shares
SC 13G · May 31, 2023
5.2%
2.3M shares
Pivotal bioVenture Partners Fund I, L.P.
SC 13D/A · May 23, 2023
6.4%
2.8M shares
Pivotal bioVenture Partners Fund I, L.P.
SC 13D/A · Apr 4, 2023
6.3%
2.7M shares
SC 13G · Mar 7, 2023
5.2%
2.1M shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G/A · Feb 14, 2023
9.3%
3.9M shares
SC 13G · Feb 14, 2023
5.1%
2.2M shares
Rock Springs Capital Management LP
SC 13G/A · Feb 14, 2023
7.6%
3.1M shares
SC 13G/A · Feb 14, 2023
8.1%
3.3M shares
SC 13G · Feb 13, 2023
5.5%
2.2M shares
SC 13G/A · Feb 10, 2023
0.0%
0 shares
Venrock Healthcare Capital Partners II, L.P.
SC 13G · Apr 29, 2022
9.8%
4.1M shares
Pivotal bioVentures Partners Fund I, L.P.
SC 13D · Apr 28, 2022
6.6%
2.7M shares
Longitude Capital Partners III, LLC
SC 13D/A · Apr 28, 2022
10.4%
4.2M shares
Rock Springs Capital Management LP
SC 13G · Apr 25, 2022
6.1%
2.5M shares
SC 13G · Apr 18, 2022
8.1%
3.3M shares
Pivotal bioVenture Partners Fund I, L.P.
SC 13G/A · Feb 14, 2022
6.7%
1.6M shares
SC 13G/A · Feb 11, 2022
9.9%
2.3M shares